1. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. (10th April 2018) Authors: Wirsching, H -G; Tabatabai, G; Roelcke, U; Hottinger, A F; Jörger, F; Schmid, A; Plasswilm, L; Schrimpf, D; Mancao, C; Capper, D; Conen, K; Hundsberger, T; Caparrotti, F; von Moos, R; Riklin, C; Felsberg, J; Roth, P; Jones, D T W; Pfister, S; Rushing, E J Journal: Annals of oncology Issue: Volume 29:Number 6(2018) Page Start: 1423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P01.108 Use of complementary and alternative medicine in glioma patients. (19th September 2018) Authors: Hertler, C; Roelcke, U; Conen, K; Huber, F; Weiss, T; Hofer, S; Heese, O; Westphal, M; Roth, P; Weller, M; Eisele, G Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗